Deepak C. D'Souza
Quick facts
Phase 1 pipeline
- DMT-Low Dose
DMT acts as an agonist at serotonin receptors, particularly 5-HT2A, producing rapid psychedelic effects through modulation of neural circuits. - DMT-Medium Dose
- THC-Medium Dose
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Related
- Sector hub: All tracked pharma companies